GSTM1 and Miyoshi myopathy: To our knowledge, this is the first study analyzing the glutathione concentration and enzyme activities in the context of deletion variants in the GSTT1 and GSTM1 genes and the response to bortezomib treatment (in low doses) in cell cultures derived from MM patients.